[Clinical late results after long-term treatment of acute femoro-iliacal thrombophlebitis].
The development of subfacial chronic insufficiency of veins (SCIV) was investigated after medicamentous treatment of acute femoroilliacal phlebothrombosises. Streptokinase (streptase) or heparin were used as medicaments. A control group of patients was treated without medicaments for the purpose of comparison. With the exception of the patients of the control group, all others were treated with oral anticoagulants for 6-7 months. Simultaneously, part of those patients treated with heparin were given a benzopyron preparation (venolat). After 1, 2, and 5 years a check-up was made for evaluating the stage of SCIV development. The best clinical late results could be found in patients of the streptokinase group. The effect of the combined administration of dicumarol and benzupyronan was markedly better than the sole anticoagulant treatment. SCIV developed most rapidly in patients of the control group. However, a check-up made 5 years after the beginning of therapy could not reveal the development of ulcers cruris in any patient.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001458:Bandages; D001510:Bed Rest; D003374:Coumarins / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011187:Posture; D011655:Pulmonary Embolism / Q000209:etiology; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000150:complications / Q000188:drug therapy*
D003374:Coumarins; D006493:Heparin; D013300:Streptokinase
Klinische Spätergebnisse nach Langzeitbehandlung von akuten femoro-iliakalen Phlebothrombosen.